Provider
Interleukin-13 (IL-13) Antagonist - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Prior Authorization, Quantity Limit
Program effective Date: Nov 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Oct 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Nov 01, 2025
Step Therapy
Program effective Date: Jan 01, 2026
Quantity Limit
Program effective Date: Jan 01, 2026
Prior Authorization, Quantity Limit
Program effective Date: May 01, 2025
Step Therapy, Quantity Limit
Program effective Date: May 01, 2025